SRCIN1 and neuroblastoma: Although the clinical relevance of SRCIN1 expression in neuroblastoma has been demonstrated, since it is an independent risk factor inversely correlated to disease aggressiveness, the importance of these genetic aberrations should be better investigated in a larger cohort of patients.